Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 428

1.

Rfx6 promotes the differentiation of peptide-secreting enteroendocrine cells while repressing genetic programs controlling serotonin production.

Piccand J, Vagne C, Blot F, Meunier A, Beucher A, Strasser P, Lund ML, Ghimire S, Nivlet L, Lapp C, Petersen N, Engelstoft MS, Thibault-Carpentier C, Keime C, Correa SJ, Schreiber V, Molina N, Schwartz TW, De Arcangelis A, Gradwohl G.

Mol Metab. 2019 Nov;29:24-39. doi: 10.1016/j.molmet.2019.08.007. Epub 2019 Aug 13.

2.

MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activity.

Sheng YH, Wong KY, Seim I, Wang R, He Y, Wu A, Patrick M, Lourie R, Schreiber V, Giri R, Ng CP, Popat A, Hooper J, Kijanka G, Florin TH, Begun J, Radford KJ, Hasnain S, McGuckin MA.

Oncogene. 2019 Nov;38(48):7294-7310. doi: 10.1038/s41388-019-0951-y. Epub 2019 Aug 19.

PMID:
31427737
3.

PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancers.

Beck C, Rodriguez-Vargas JM, Boehler C, Robert I, Heyer V, Hanini N, Gauthier LR, Tissier A, Schreiber V, Elofsson M, Reina San Martin B, Dantzer F.

Cell Death Differ. 2019 Sep;26(9):1615-1630. doi: 10.1038/s41418-018-0233-1. Epub 2018 Nov 15.

PMID:
30442946
4.

Purification of Recombinant Human PARG and Activity Assays.

Amé JC, Héberlé É, Camuzeaux B, Dantzer F, Schreiber V.

Methods Mol Biol. 2017;1608:395-413. doi: 10.1007/978-1-4939-6993-7_25.

PMID:
28695523
5.

Purification of Recombinant Human PARP-3.

Amé JC, Camuzeaux B, Dantzer F, Schreiber V.

Methods Mol Biol. 2017;1608:373-394. doi: 10.1007/978-1-4939-6993-7_24.

PMID:
28695522
6.

The Central Vacuole of the Diatom Phaeodactylum tricornutum: Identification of New Vacuolar Membrane Proteins and of a Functional Di-leucine-based Targeting Motif.

Schreiber V, Dersch J, Puzik K, Bäcker O, Liu X, Stork S, Schulz J, Heimerl T, Klingl A, Zauner S, Maier UG.

Protist. 2017 Jul;168(3):271-282. doi: 10.1016/j.protis.2017.03.001. Epub 2017 Mar 15.

PMID:
28495413
7.

PARP-1/PARP-2 double deficiency in mouse T cells results in faulty immune responses and T lymphomas.

Navarro J, Gozalbo-López B, Méndez AC, Dantzer F, Schreiber V, Martínez C, Arana DM, Farrés J, Revilla-Nuin B, Bueno MF, Ampurdanés C, Galindo-Campos MA, Knobel PA, Segura-Bayona S, Martin-Caballero J, Stracker TH, Aparicio P, Del Val M, Yélamos J.

Sci Rep. 2017 Feb 9;7:41962. doi: 10.1038/srep41962.

8.

Robust immunoglobulin class switch recombination and end joining in Parp9-deficient mice.

Robert I, Gaudot L, Yélamos J, Noll A, Wong HK, Dantzer F, Schreiber V, Reina-San-Martin B.

Eur J Immunol. 2017 Apr;47(4):665-676. doi: 10.1002/eji.201646757. Epub 2017 Feb 22.

9.

The evolution of primary double-bundle ACL reconstruction and recovery of early post-operative range of motion.

Schreiber VM, Jordan SS, Bonci GA, Irrgang JJ, Fu FH.

Knee Surg Sports Traumatol Arthrosc. 2017 May;25(5):1475-1481. doi: 10.1007/s00167-016-4347-z. Epub 2016 Oct 14.

PMID:
27743079
10.

Autophagy requires poly(adp-ribosyl)ation-dependent AMPK nuclear export.

Rodríguez-Vargas JM, Rodríguez MI, Majuelos-Melguizo J, García-Diaz Á, González-Flores A, López-Rivas A, Virág L, Illuzzi G, Schreiber V, Dantzer F, Oliver FJ.

Cell Death Differ. 2016 Dec;23(12):2007-2018. doi: 10.1038/cdd.2016.80. Epub 2016 Sep 30.

11.

Expanding functions of ADP-ribosylation in the maintenance of genome integrity.

Martin-Hernandez K, Rodriguez-Vargas JM, Schreiber V, Dantzer F.

Semin Cell Dev Biol. 2017 Mar;63:92-101. doi: 10.1016/j.semcdb.2016.09.009. Epub 2016 Sep 23. Review.

PMID:
27670719
12.

PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.

Karicheva O, Rodriguez-Vargas JM, Wadier N, Martin-Hernandez K, Vauchelles R, Magroun N, Tissier A, Schreiber V, Dantzer F.

Oncotarget. 2016 Sep 27;7(39):64109-64123. doi: 10.18632/oncotarget.11627.

13.

Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism.

Oancea I, Movva R, Das I, Aguirre de Cárcer D, Schreiber V, Yang Y, Purdon A, Harrington B, Proctor M, Wang R, Sheng Y, Lobb M, Lourie R, Ó Cuív P, Duley JA, Begun J, Florin TH.

Gut. 2017 Jan;66(1):59-69. doi: 10.1136/gutjnl-2015-310874. Epub 2016 Jul 13.

14.

Is There a Difference in Graft Motion for Bone-Tendon-Bone and Hamstring Autograft ACL Reconstruction at 6 Weeks and 1 Year?

Irvine JN, Arner JW, Thorhauer E, Abebe ES, D'Auria J, Schreiber VM, Harner CD, Tashman S.

Am J Sports Med. 2016 Oct;44(10):2599-2607. Epub 2016 Jul 13.

PMID:
27411358
15.

PARG deficiency is neither synthetic lethal with BRCA1 nor PTEN deficiency.

Noll A, Illuzzi G, Amé JC, Dantzer F, Schreiber V.

Cancer Cell Int. 2016 Jul 1;16:53. doi: 10.1186/s12935-016-0333-2. eCollection 2016.

16.

High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22.

Gulhane M, Murray L, Lourie R, Tong H, Sheng YH, Wang R, Kang A, Schreiber V, Wong KY, Magor G, Denman S, Begun J, Florin TH, Perkins A, Cuív PÓ, McGuckin MA, Hasnain SZ.

Sci Rep. 2016 Jun 28;6:28990. doi: 10.1038/srep28990.

17.

Poly(ADP-ribosyl)ation of methyl CpG binding protein 2 regulates chromatin structure.

Becker A, Zhang P, Allmann L, Meilinger D, Bertulat B, Eck D, Hofstaetter M, Bartolomei G, Hottiger MO, Schreiber V, Leonhardt H, Cardoso MC.

J Biol Chem. 2016 Apr 22;291(17):9382. doi: 10.1074/jbc.A115.698357. No abstract available.

18.

Poly(ADP-ribosyl)ation of Methyl CpG Binding Domain Protein 2 Regulates Chromatin Structure.

Becker A, Zhang P, Allmann L, Meilinger D, Bertulat B, Eck D, Hofstaetter M, Bartolomei G, Hottiger MO, Schreiber V, Leonhardt H, Cardoso MC.

J Biol Chem. 2016 Mar 4;291(10):4873-81. doi: 10.1074/jbc.M115.698357. Epub 2016 Jan 15. Erratum in: J Biol Chem. 2016 Apr 22;291(17):9382.

19.

[From poly(ADP-ribose) discovery to PARP inhibitors in cancer therapy].

Schreiber V, Illuzzi G, Héberlé E, Dantzer F.

Bull Cancer. 2015 Oct;102(10):863-73. doi: 10.1016/j.bulcan.2015.07.012. Epub 2015 Sep 15. Review. French.

PMID:
26384693
20.

Exercise-induced Pediatric Lumbar Paravertebral Compartment Syndrome: A Case Report.

Schreiber VM, Ward WT.

J Pediatr Orthop. 2015 Sep;35(6):e49-51. doi: 10.1097/BPO.0000000000000478.

PMID:
25887821
21.

[The role of PARP2 in DNA repair].

Kutuzov MM, Khodyreva SN, Schreiber V, Lavrik OI.

Mol Biol (Mosk). 2014 Jul-Aug;48(4):561-72. Review. Russian.

22.

A simple method for comparing enzymatic capecitabine activation in various mono- and combination chemotherapies.

Buchner P, Sahmanovic A, Schreiber V, Baroian N, Dittrich C, Czejka M.

Pharmacology. 2015;95(1-2):29-31. doi: 10.1159/000369934. Epub 2015 Jan 9.

PMID:
25591914
23.

Mean hemoglobin concentration after acute subarachnoid hemorrhage and the relation to outcome, mortality, vasospasm, and brain infarction.

Stein M, Brokmeier L, Herrmann J, Scharbrodt W, Schreiber V, Bender M, Oertel MF.

J Clin Neurosci. 2015 Mar;22(3):530-4. doi: 10.1016/j.jocn.2014.08.026. Epub 2014 Dec 18.

PMID:
25533213
24.

PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors.

Farrés J, Llacuna L, Martin-Caballero J, Martínez C, Lozano JJ, Ampurdanés C, López-Contreras AJ, Florensa L, Navarro J, Ottina E, Dantzer F, Schreiber V, Villunger A, Fernández-Capetillo O, Yélamos J.

Cell Death Differ. 2015 Jul;22(7):1144-57. doi: 10.1038/cdd.2014.202. Epub 2014 Dec 12.

25.

Global discrepancies in the diagnosis, surgical management, and investigation of femoroacetabular impingement.

Yeung M, Khan M, Schreiber VM, Adamich J, Letkemann S, Simunovic N, Bhandari M, Musahl V, Philippon MJ, Safran MR, Ayeni OR.

Arthroscopy. 2014 Dec;30(12):1625-33. doi: 10.1016/j.arthro.2014.06.008. Epub 2014 Aug 20. Review.

PMID:
25150405
26.

Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's disease.

Neudorfer C, Shanab K, Jurik A, Schreiber V, Neudorfer C, Vraka C, Schirmer E, Holzer W, Ecker G, Mitterhauser M, Wadsak W, Spreitzer H.

Bioorg Med Chem Lett. 2014 Sep 15;24(18):4490-4495. doi: 10.1016/j.bmcl.2014.07.085. Epub 2014 Aug 7.

PMID:
25127869
27.

Poly(ADP-ribose) polymerases in double-strand break repair: focus on PARP1, PARP2 and PARP3.

Beck C, Robert I, Reina-San-Martin B, Schreiber V, Dantzer F.

Exp Cell Res. 2014 Nov 15;329(1):18-25. doi: 10.1016/j.yexcr.2014.07.003. Epub 2014 Jul 10. Review.

PMID:
25017100
28.

Impact of co-administered drugs on drug monitoring of capecitabine in patients with advanced colorectal cancer.

Schreiber V, Kitzmueller M, Poxhofer M, Gintersdorfer S, Neudorfer C, Lichtneckert M, Dittrich C, Czejka M.

Anticancer Res. 2014 Jul;34(7):3371-6.

PMID:
24982342
29.

PARG is dispensable for recovery from transient replicative stress but required to prevent detrimental accumulation of poly(ADP-ribose) upon prolonged replicative stress.

Illuzzi G, Fouquerel E, Amé JC, Noll A, Rehmet K, Nasheuer HP, Dantzer F, Schreiber V.

Nucleic Acids Res. 2014 Jul;42(12):7776-92. doi: 10.1093/nar/gku505. Epub 2014 Jun 6.

30.

Poly(ADP-ribose) polymerase 1 (PARP1) associates with E3 ubiquitin-protein ligase UHRF1 and modulates UHRF1 biological functions.

De Vos M, El Ramy R, Quénet D, Wolf P, Spada F, Magroun N, Babbio F, Schreiber V, Leonhardt H, Bonapace IM, Dantzer F.

J Biol Chem. 2014 Jun 6;289(23):16223-38. doi: 10.1074/jbc.M113.527424. Epub 2014 Apr 29.

31.

PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways.

Beck C, Boehler C, Guirouilh Barbat J, Bonnet ME, Illuzzi G, Ronde P, Gauthier LR, Magroun N, Rajendran A, Lopez BS, Scully R, Boussin FD, Schreiber V, Dantzer F.

Nucleic Acids Res. 2014 May;42(9):5616-32. doi: 10.1093/nar/gku174. Epub 2014 Mar 5.

32.

PARP1-TDP1 coupling for the repair of topoisomerase I-induced DNA damage.

Das BB, Huang SY, Murai J, Rehman I, Amé JC, Sengupta S, Das SK, Majumdar P, Zhang H, Biard D, Majumder HK, Schreiber V, Pommier Y.

Nucleic Acids Res. 2014 Apr;42(7):4435-49. doi: 10.1093/nar/gku088. Epub 2014 Feb 3.

33.

Parp-2 is required to maintain hematopoiesis following sublethal γ-irradiation in mice.

Farrés J, Martín-Caballero J, Martínez C, Lozano JJ, Llacuna L, Ampurdanés C, Ruiz-Herguido C, Dantzer F, Schreiber V, Villunger A, Bigas A, Yélamos J.

Blood. 2013 Jul 4;122(1):44-54. doi: 10.1182/blood-2012-12-472845. Epub 2013 May 15.

34.

What is the rate of methicillin-resistant Staphylococcus aureus and Gram-negative infections in open fractures?

Chen AF, Schreiber VM, Washington W, Rao N, Evans AR.

Clin Orthop Relat Res. 2013 Oct;471(10):3135-40. doi: 10.1007/s11999-013-2855-4.

35.

Functional aspects of PARylation in induced and programmed DNA repair processes: preserving genome integrity and modulating physiological events.

Robert I, Karicheva O, Reina San Martin B, Schreiber V, Dantzer F.

Mol Aspects Med. 2013 Dec;34(6):1138-52. doi: 10.1016/j.mam.2013.02.001. Epub 2013 Feb 26. Review.

PMID:
23454615
36.

Interaction of PARP-2 with DNA structures mimicking DNA repair intermediates and consequences on activity of base excision repair proteins.

Kutuzov MM, Khodyreva SN, Amé JC, Ilina ES, Sukhanova MV, Schreiber V, Lavrik OI.

Biochimie. 2013 Jun;95(6):1208-15. doi: 10.1016/j.biochi.2013.01.007. Epub 2013 Jan 26.

PMID:
23357680
37.

Short-term preoperative supplementation of an immunoenriched diet does not improve clinical outcome in well-nourished patients undergoing abdominal cancer surgery.

Giger-Pabst U, Lange J, Maurer C, Bucher C, Schreiber V, Schlumpf R, Kocher T, Schweizer W, Krähenbühl S, Krähenbühl L.

Nutrition. 2013 May;29(5):724-9. doi: 10.1016/j.nut.2012.10.007. Epub 2013 Jan 22.

PMID:
23352174
38.

The use of blood vessel-derived stem cells for meniscal regeneration and repair.

Osawa A, Harner CD, Gharaibeh B, Matsumoto T, Mifune Y, Kopf S, Ingham SJ, Schreiber V, Usas A, Huard J.

Med Sci Sports Exerc. 2013 May;45(5):813-23. doi: 10.1249/MSS.0b013e31827d1e06.

39.

Poly (ADP-ribose) glycohydrolase regulates retinoic acid receptor-mediated gene expression.

Le May N, Iltis I, Amé JC, Zhovmer A, Biard D, Egly JM, Schreiber V, Coin F.

Mol Cell. 2012 Dec 14;48(5):785-98. doi: 10.1016/j.molcel.2012.09.021. Epub 2012 Oct 25.

40.

New readers and interpretations of poly(ADP-ribosyl)ation.

Kalisch T, Amé JC, Dantzer F, Schreiber V.

Trends Biochem Sci. 2012 Sep;37(9):381-90. doi: 10.1016/j.tibs.2012.06.001. Epub 2012 Jul 3. Review.

PMID:
22766145
41.

The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art.

De Vos M, Schreiber V, Dantzer F.

Biochem Pharmacol. 2012 Jul 15;84(2):137-46. doi: 10.1016/j.bcp.2012.03.018. Epub 2012 Mar 31. Review.

PMID:
22469522
42.

Phenotypic characterization of Parp-1 and Parp-2 deficient mice and cells.

Boehler C, Gauthier L, Yelamos J, Noll A, Schreiber V, Dantzer F.

Methods Mol Biol. 2011;780:313-36. doi: 10.1007/978-1-61779-270-0_19.

PMID:
21870269
43.

Purification of recombinant poly(ADP-ribose) polymerases.

Amé JC, Kalisch T, Dantzer F, Schreiber V.

Methods Mol Biol. 2011;780:135-52. doi: 10.1007/978-1-61779-270-0_9.

PMID:
21870259
44.

Recurrent intrahepatic dislocation of ventriculoperitoneal shunt.

Berkmann S, Schreiber V, Khamis A.

Minim Invasive Neurosurg. 2011 Apr;54(2):83-6. doi: 10.1055/s-0031-1277174. Epub 2011 Jun 7.

PMID:
21656443
45.

[PARP inhibitors: significant progress in cancer therapy].

Dantzer F, Noel G, Schreiber V.

Bull Cancer. 2011 Mar;98(3):277-90. doi: 10.1684/bdc.2011.1330. Review. French.

46.

PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation.

Bai P, Cantó C, Oudart H, Brunyánszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, Schoonjans K, Schreiber V, Sauve AA, Menissier-de Murcia J, Auwerx J.

Cell Metab. 2011 Apr 6;13(4):461-468. doi: 10.1016/j.cmet.2011.03.004.

47.

PARP-2 regulates SIRT1 expression and whole-body energy expenditure.

Bai P, Canto C, Brunyánszki A, Huber A, Szántó M, Cen Y, Yamamoto H, Houten SM, Kiss B, Oudart H, Gergely P, Menissier-de Murcia J, Schreiber V, Sauve AA, Auwerx J.

Cell Metab. 2011 Apr 6;13(4):450-460. doi: 10.1016/j.cmet.2011.03.013.

48.

PARG is recruited to DNA damage sites through poly(ADP-ribose)- and PCNA-dependent mechanisms.

Mortusewicz O, Fouquerel E, Amé JC, Leonhardt H, Schreiber V.

Nucleic Acids Res. 2011 Jul;39(12):5045-56. doi: 10.1093/nar/gkr099. Epub 2011 Mar 11.

49.

Clinical and methodological precision of spinal navigation assisted by 3D intraoperative O-arm radiographic imaging.

Oertel MF, Hobart J, Stein M, Schreiber V, Scharbrodt W.

J Neurosurg Spine. 2011 Apr;14(4):532-6. doi: 10.3171/2010.10.SPINE091032. Epub 2011 Jan 28.

PMID:
21275555
50.

Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression.

Boehler C, Gauthier LR, Mortusewicz O, Biard DS, Saliou JM, Bresson A, Sanglier-Cianferani S, Smith S, Schreiber V, Boussin F, Dantzer F.

Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2783-8. doi: 10.1073/pnas.1016574108. Epub 2011 Jan 26.

Supplemental Content

Loading ...
Support Center